This suggests that anti‐NT5C1A antibody can be detected in autoimmune diseases other than IBM, however, seropositivity for anti‐NT5C1A antibody in IIMs other than IBM has not been assessed within a large population. Here, NT5C1A is linked to inclusion body myositis.